Table 2 Biologic characteristics of AVF patency and dysfunction group.

From: Risk factors for arteriovenous fistula dysfunction in hemodialysis patients: a retrospective study

Characteristic

Overall (n = 233)

Patency (n = 191)

Dysfunction (n = 42)

Z/t

P

TC (mmol/L)

4.09 (3.33, 5.01)

4.12 (3.39, 4.93)

3.84 (3.19, 5.48)

− 0.05

0.96

TG (mmol/L)

1.44 (0.97, 2.07)

1.44 (0.97, 2.10)

1.43 (0.97, 1.92)

− 0.24

0.81

HDL (mmol/L)

0.99 (0.82, 1.27)

0.99 (0.82, 1.25)

1.00 (0.76, 1.29)

− 0.10

0.92

LDL (mmol/L)

1.98 (1.44, 2.69)

1.99 (1.46, 2.69)

1.81 (1.00, 3.08)

− 0.86

0.39

PLT (× 109/L)

195.59 ± 82.21

193.57 ± 79.93

204.74 ± 92.32

− 0.80

0.43

MPV (fl)

10.24 ± 1.46

10.19 ± 1.42

10.46 ± 1.63

− 1.11

0.27

PDW (fl)

15.60 (11.20, 41.40)

15.60 (11.20, 42.50)

15.45 (10.85, 18.35)

− 0.08

0.93

WBC (× 109/L)

6.60 (4.95, 8.43)

6.77 (4.85, 8.45)

6.37 (5.33, 7.35)

− 0.33

0.74

PTH (pg/ml)

263.7 (147.0, 446.6)

277.2 (153.1, 450.0)

224.1 (120.4, 374.6)

− 1.31

0.19

NEU (× 109/L)

4.82 (3.39, 6.32)

4.89 (3.38, 6.32)

4.62 (3.42, 6.15)

− 0.30

0.77

MONO (× 109/L)

0.43 (0.31, 0.56)

0.43 (0.31, 0.56)

0.46 (0.34, 0.57)

− 0.72

0.47

LYMPH (× 109/L)

0.90 (0.70, 1.26)

0.90 (0.71, 1.27)

0.85 (0.70, 1.25)

− 0.40

0.67

NLR

4.70 (3.36, 7.76)

4.75 (3.19, 7.90)

4.56 (3.69, 7.01)

− 0.01

1.00

PLR

195.6 (134.7, 278.1)

184.5 (134.0, 271.4)

217.2 (148.3, 304.5)

− 1.08

0.28

β2MG (mg/L)

21.35 (16.46, 26.73)

21.24 (16.41, 26.72)

22.46 (16.43, 27.90)

− 0.56

0.58

ALB (g/L)

32.84 (28.83, 36.56)

33.69 (29.20, 37.00)

30.29 (27.55, 34.70)

− 2.62

0.01

Fer (ng/ml)

211.6 (90.1, 375.0)

211.6 (88.7, 375.0)

222.5 (102.2, 385.9)

− 0.02

0.99

HB(g/L)

82.62 ± 18.49

82.42 ± 18.13

83.55 ± 20.24

− 0.36

0.72

RBC (× 109/L)

2.76 (2.32, 3.17)

2.67 (2.32, 317)

2.85 (2.34, 3.21)

− 0.62

0.53

GLU (mmol/L)

4.89 (4.16, 6.63)

4.89 (4.16, 6.28)

4.90 (4.14, 7.44)

− 0.42

0.68

Antithrombin III activity

97.9 (90.9, 105.7)

98.4 (92.9, 106.0)

93.90 (87.30, 106.50)

− 1.58

0.11

PTA

98.43 ± 20.29

99.95 ± 19.60

91.84 ± 22.14

2.09

0.04

PT (sec)

11.10 (10.60, 11.83)

11.00 (10.60, 11.72)

11.30 (10.50, 12.10)

− 0.62

0.53

PCT (ng/ml)

0.14 (0.06, 0.40)

0.14 (0.06, 0.40)

0.13 (0.05, 0.46)

− 0.33

0.74

Ca (mmol/L)

1.98 ± 0.33

2.00 ± 0.32

1.90 ± 0.38

1.77

0.08

P (mmol/L)

1.88 (1.46, 2.40)

1.84 (1.45, 2.37)

2.03 (1.63, 2.58)

− 1.64

0.10

Ca × Pi

44.77 (36.12, 56.25)

44.27 (35.79, 55.94)

50.59 (38.00, 58.51)

− 1.22

0.22

Creatinine (umol/L)

750.9 (604.5, 944.5)

750.9 (596.7, 946.8)

749.0 (609.8, 936.6)

− 0.12

0.91

Uric acid (umol/L)

487.32 ± 139.54

498.03 ± 136.78

439.41 ± 143.34

2.49

0.01

Urea nitrogen (mmol/L)

19.3 (23.6, 30.2)

23.5 (19.3, 30.8)

24.00 (19.09, 29.32)

− 0.04

0.97

K (mmol/L)

4.41 (3.90, 5.17)

4.37 (3.88, 5.12)

4.55 (3.91, 5.22)

− 0.90

0.37

eGFR (ml/min/1.73m2)

5.49 (3.99, 7.11)

5.41 (3.99, 7.11)

5.78 (3.89, 7.21)

− 0.39

0.70

D-dimer (ug/ml)

1.22 (0.62, 3.16)

1.09 (0.58, 2.82)

1.78 (0.87, 3.86)

− 1.68

0.09

  1. TC total cholesterol, TG triglyceride, HDL high-density lipoprotein, LDL low-density lipoprotein, PLT platelets, PDW platelet distribution width, MPV mean platelet volume, WBC white blood cells, PTH parathyroid hormone, β2MG β2 microglobulin, ALB albumin, Fer ferritin, HB hemoglobin, RBC red blood cells, GLU glucose, PTA prothrombin activity, PT prothrombin time, PCT procalcitonin, Ca calcium, P phosphorus, eGFR estimated glomerular filtration rate.
  2. Categorical variables are presented as number (%). Continuous variables with Gaussian distribution are presented as mean ± standard deviations;
  3. P for comparison between patients with AVF patency and AVF dysfunction.
  4. Significant values are in bold.
Back to article page